Infliximab (chimeric antitumour necrosis factor a monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomized phase III trial - Maini, R, St; Clair, E W; Breedveld, F (Lancet, 1999)
et al.